This NOFO is intended to increase the capacity and capability of newborn screening laboratories to test for newborn screening conditions as recommended by the U.
S.
Department of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children.
This
credit:
NOFO is also intended to improve newborn screening test performance and test interpretation of dried blood spot newborn screening.